Safety and Dose Finding Trial of BM32 in Subjects Suffering From Grass Pollen Allergy

Grass Pollen Allergy Clinical Trial

Official title:
Safety and Dose Finding Study Based on the Effects of Three Subcutaneous Injections of BM32, a Recombinant Hypoallergenic Grass Pollen Vaccine, on Responses to Allergen Challenge by Skin Testing and in the Vienna Challenge Chamber (VCC) as Well as Immunological Response in Subjects Know to Suffer From Grass-pollen Induced Allergic Rhinitis

Status Completed

Clinical Trial Summary

The study will evaluate the dose response of immunotherapy against grass pollen allergy using the recombinant grass pollen vaccine BM32. Efficacy will be analyzed by:

- skin prick testing

- grass pollen inhalation challenge

- antibody responses. In addition, the safety of subcutaneous application of BM32 will be evaluated.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01445002
Study type	Interventional
Source	Biomay AG
Contact
Status	Completed
Phase	Phase 2
Start date	October 2011
Completion date	October 2012

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05560698` - A Motivation-enhancing App to Retain Patients With Hay Fever in a Trial After Treatment	N/A
Completed	`NCT01830673` - Regulatory T-cells After Subcutaneous Immunotherapy	N/A
Active, not recruiting	`NCT04502966` - Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction	Phase 2
Completed	`NCT00263601` - Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis	Phase 3
Completed	`NCT01538979` - Phase II Study of Grass Pollen Allergy Vaccine BM32	Phase 2
Completed	`NCT04435678` - Diagnostic Accuracy of the MADx Multi Array Xplorer (MAX 45k) Automated Laboratory System and the MADx Allergy Explorer Version 2 (ALEX²) - IgE Multiplex Test for the Diagnosis of Pre-defined Groups of Specific High-priority Allergens	N/A
Completed	`NCT00264459` - Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture	Phase 3
Completed	`NCT01308021` - Clinical Efficacy and Safety of gpASIT+TM to Treat Seasonal Allergic Rhinoconjunctivitis	Phase 2
Completed	`NCT00773240` - A Phase III Trial Assessing the Pharmacodynamic Effect and the Tolerability of Grazax Treatment	Phase 3